You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-MADD (MADD) Antibodies

Full name:
anti-MAP-Kinase Activating Death Domain Antibodies (MADD)
On are 37 MAP-Kinase Activating Death Domain (MADD) Antibodies from 18 different suppliers available. Additionally we are shipping MADD Kits (5) and and many more products for this protein. A total of 49 MADD products are currently listed.
9630059K23Rik, DENN, IG20, MADD, MGC145371, RAB3GEP

Most Popular Reactivities for anti-MADD (MADD) Antibodies

Select your species and application

anti-Human MADD Antibodies:

anti-Mouse (Murine) MADD Antibodies:

anti-Rat (Rattus) MADD Antibodies:

All available anti-MADD Antibodies

Go to our pre-filtered search.

Top referenced anti-MADD Antibodies

  1. Human Polyclonal MADD Primary Antibody for EIA, IF - ABIN500216 : Chow, Lee: DENN, a novel human gene differentially expressed in normal and neoplastic cells. in DNA sequence : the journal of DNA sequencing and mapping 1997 (PubMed)
    Show all 4 references for ABIN500216

  2. Human Polyclonal MADD Primary Antibody for IHC (fro), WB - ABIN2475471 : Schievella, Chen, Graham, Lin: MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. in The Journal of biological chemistry 1997 (PubMed)
    Show all 2 references for ABIN2475471

  3. Human Polyclonal MADD Primary Antibody for IF, IHC - ABIN1534033 : Chow, Lim, Lim: The human DENN gene: genomic organization, alternative splicing, and localization to chromosome 11p11.21-p11.22. in Genome / National Research Council Canada = Génome / Conseil national de recherches Canada 1998 (PubMed)

More Antibodies against MADD Interaction Partners

Human MAP-Kinase Activating Death Domain (MADD) interaction partners

  1. Taken together, our data reveal that PTEN (show PTEN Antibodies) can convey the death signal by preventing MADD (show ETFA Antibodies) phosphorylation by Akt (show AKT1 Antibodies).

  2. These results suggest that MADD (show ETFA Antibodies) may be a potential therapeutic target for lung adenocarcinoma therapy involving the TRAIL-induced apoptosis pathway

  3. MADD (show ETFA Antibodies) knockdown resulted in enhanced spontaneous apoptosis in human breast cancer cell lines

  4. We analyzed DENN/MADD/IG20 (DMI), the complex of four splice variants in Alzheimer's disease.

  5. SNP rs2290149, located in a genetic cluster of MYBPC3 (show MYBPC3 Antibodies) and MADD (show ETFA Antibodies) gene, was found to be associated with diastolic heart failure.

  6. Data show that ehe expression of MAPK (show MAPK1 Antibodies)-activating death domain protein (MADD (show ETFA Antibodies)) increases obviously in lung adenocarcinoma, and MADD (show ETFA Antibodies) can promote survival of lung adenocarcinoma cells by inhibiting apoptosis.

  7. The SNP in ADCY5 (show ADCY5 Antibodies) is implicated in defective proinsulin (show INS Antibodies)-to-insulin (show INS Antibodies) conversion and previous findings on the role of a genetic variant in MADD (show ETFA Antibodies) on proinsulin (show INS Antibodies)-to-insulin (show INS Antibodies) conversion, were confirmed.

  8. Data show that SNPs from MADD (show ETFA Antibodies), PROX1 (show PROX1 Antibodies), and SLC30A8 (show SLC30A8 Antibodies) were associated with type 2 diabetes.

  9. Endogenous MADD (show ETFA Antibodies) is phosphorylated at three highly conserved sites by Akt (show AKT1 Antibodies), and only the phosphorylated MADD (show ETFA Antibodies) can directly interact with the TRAIL receptor DR4 (show HLADRB4 Antibodies) thereby preventing Fas (show FAS Antibodies)-associated death domain recruitment.

  10. Denn is intimately involved in anti-apoptotic and cell survival processes in cancer cells

Mouse (Murine) MAP-Kinase Activating Death Domain (MADD) interaction partners

  1. These findings indicated that IG20/MADD plays a critical role in glucose-induced insulin (show INS Antibodies) release from beta-cells and that its functional disruption can cause type 2 diabetes.

  2. role of Rab3 GEP in regulating neurotransmitter release in autapses of mouse hippocampal neurons in culture

  3. DENN has anti-apoptotic and cell survival roles in tumor cells

MADD Antigen Profile

Antigen Summary

Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells by cytoplasmic adaptor proteins. The protein encoded by this gene is a death domain-containing adaptor protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activated protein kinase (MAPK) and propagate the apoptotic signal. It is membrane-bound and expressed at a higher level in neoplastic cells than in normal cells. Several transcript variants encoding different isoforms have been described for this gene.

Alternative names and synonyms associated with MADD

  • MAP-kinase activating death domain (MADD) antibody
  • MAP-kinase activating death domain (madd) antibody
  • MAP-kinase activating death domain (Madd) antibody
  • 9630059K23Rik antibody
  • DENN antibody
  • IG20 antibody
  • MADD antibody
  • MGC145371 antibody
  • RAB3GEP antibody

Protein level used designations for MADD

MAP-kinase activating death domain , MAP kinase-activating death domain protein , MAP kinase-activating death domain protein-like , Rab3 GDP/GTP exchange factor , differentially expressed in normal and neoplastic cells , insulinoma glucagonoma clone 20 , Rab3 GDP/GTP exchange protein , Rab3 GEP , insulinoma-glucagonoma protein 20 , rab3 GDP/GTP exchange factor

423184 Gallus gallus
475982 Canis lupus familiaris
534306 Bos taurus
780174 Xenopus (Silurana) tropicalis
100051327 Equus caballus
100390785 Callithrix jacchus
100474806 Ailuropoda melanoleuca
100514701 Sus scrofa
100567890 Anolis carolinensis
8567 Homo sapiens
228355 Mus musculus
94193 Rattus norvegicus
Selected quality suppliers for anti-MADD (MADD) Antibodies
Did you look for something else?